Introduction: in 2009 and 2010, more than 6,000 cholera cases were recorded during these outbreaks with more than 80% of cases recorded in Lusaka province. After a five-year break, in 2016 an outbreak occurred in Lusaka, causing more than 1,000 cases of cholera. This study will strengthen the epidemiological information on the changing characteristics of the cholera outbreaks, for treatment, prevention and control of the disease.
Introduction
Cholera is an enteric disease of immense public health concern, causing an estimated 2.8 million cases with 91,000 deaths globally every year [1] . It is an acute disease characterised by severe watery diarrhoea caused by toxigenic Vibrio cholerae strains belonging to serogroups O1 and O139 [2] . The bacteria colonise the small intestine and produce an enterotoxin known as cholera toxin (CT) [3] .
Pandemics that are caused by this bacterium have severely affected many countries on multiple continents for many years [4] . Cholera is transmitted via the faeco-oral route and is particularly associated with poverty and poor sanitation [3] . The first cholera outbreak in Africa was reported in 1836 along the Indian Ocean coast killing about 20,000 people [5] . No further outbreak was reported on the continent after the 1893-1894 outbreak in the Senegambia region until the seventh pandemic reached the continent in 1970 [6] . This pandemic caused massive outbreaks in Africa resulting in more than 400,000 cases with a high mortality rate [7] . Between 1995 and 2005, Africa experienced a greater upsurge in cholera outbreaks than other continents, with over 80% of the global total number of cholera cases [8] . The trend of Africa reporting more cholera cases continued between 2006 and 2010 [9] . In addition over the past 10 years, several Southern African countries, such as Mozambique [10], Tanzania [11] , Zimbabwe [12], South Africa [2] and Zambia [13] have reported cholera outbreaks. Zambia usually experiences cholera outbreaks during the rainy season and most of them have been associated with fishing camps, especially in the northern part of the country and in unplanned settlements of Lusaka and Copperbelt Provinces [14] . The first cholera outbreak in Zambia was reported in the 1970s and several other outbreaks have occurred over the years, with the worst outbreak being in 1991 that resulted in over 13,000 cases [15]. In the 2009 outbreak, a total of 4,712 cases were reported, while the 2010 cholera outbreak caused 6,794 cases, with the majority of the cases being from Lusaka Province [13, 14] . In 2016 between February and June, Zambia experienced an outbreak with more than 1000 cases and 22 deaths being reported from Lusaka Province alone after a quiescent period of 5 years [16] . In order to minimize the disease burden caused by cholera, antimicrobial drugs have been used against V. cholerae O1 to shorten the duration of illness and to reduce the volume of stools produced [17] . However, the increased use of antibiotics against cholera has resulted in the emergence of multiple drug resistance in Zambia and other parts of the world [18] [19] [20] [21] . During the 2009, 2010 and 2016 cholera outbreaks, Lusaka reported the highest number of cholera cases in Zambia [14] . Therefore, this study sought to describe the phenotypic characteristics of V. cholerae O1 strains isolated from Lusaka during these three cholera outbreaks through serotyping and antibiotic susceptibility testing, and their genetic diversity by macrorestriction analysis using Pulsed-Field Gel Electrophoresis (PFGE). 
Methods

Discussion
Cholera outbreaks continue to be major public health threat in Lusaka
Province. These outbreaks usually occur in peri-urban townships that are densely populated and have inadequate water and sanitation facilities, a scenario that favours the spread of the disease. Mozambique [24] , Kenya [25] and Ghana [26] . However, a study in the Democratic Republic of Congo (DRC) reported some strains belonging to another serotype, Hikojima, during a 2009 cholera outbreak there [27] . It is interesting to note that a different serotype was reported from the DRC, a country that shares a long border area with Zambia on its southern side. This calls for vigilance against the Hikojima serotype, especially during screening exercises for cholera cases that may arise from this border area. Molecular epidemiology of human bacterial pathogens provides valuable information for understanding the reservoir, pathogenicity and control of bacterial pathogens [28] .
Macro restriction analysis data revealed 16 patterns among all the isolates, with those from 2009 and 2010 outbreak clustering together.
This suggests that these isolates were closely related and that those from the 2009 outbreak may have continued to cause infection during the 2010 cholera outbreak. This phenomenon has also been reported in Kenya [25] , South Africa [29] and India [30] . The 2016 isolates, however, formed unique clusters, suggesting the emergence of a new clade of the Ogawa serotype causing the cholera outbreak in Lusaka.
Similar findings were also reported in a previous Zambian study on outbreak strains isolated between 1996 and 2004 in Zambia, which revealed the emergence of new V. cholerae strains [31] . Yet another study in Haiti showed the same phenomenon [32] . These findings suggest that the evolution of V. cholerae led to a shift between serotypes Inaba and Ogawa [33] . The strains in this current study generally exhibited high genetic diversity with one isolate, from the 2016 outbreak, not showing any relationship with any of the other isolates. This high genetic diversity seems to suggest that the isolates did not have the same origin [34] . The increase in AMR among enteropathogens, especially MDR strains, is challenging global prospects for fighting diarrhoeal disease pathogens. The emergence and spread of MDR pathogens outstrips the development of drugs,
shrinking the therapeutic arsenal [35] . In this study, all the organisms were totally resistant to nalidixic acid and partially resistant to ampicillin. A previous Zambian study, during the 1990-1991 major cholera outbreak, showed low resistance of V. cholerae O1 strains to cotrimoxazole, tetracycline, chloramphenicol and doxycycline but significant increase in AMR during subsequent outbreaks [18] .
The high resistance observed with cotrimoxazole supports our findings among the 2009 and 2010 isolates, but interestingly very low resistance to this drug was observed among the 2016 isolates. In consonance with our findings from all the three outbreaks, a Nepalese study reported 100% resistance to nalidixic acid [36] . High rates of sensitivity to azithromycin were also reported in a study carried out in Iran, which was in accordance with our findings where only 1.2% resistance was reported [37] . Unlike the findings in this study, high resistance levels to tetracycline (82%) were reported in Mozambique [24] . In this current study, the emergence of MDR [25] and Ghana [26] . Differences in the antibiotic resistance patterns observed during the three outbreaks and the emergence of MDR strains may be attributed to a spontaneous mutation that results from the abuse of antibiotics and horizontal gene transfer [41] . This study presents data that underscores the need for close monitoring of V. cholerae strains that cause cholera outbreaks in Zambia. This is important to ensure that the correct antibiotic is chosen according to resistance variations, considering the increasing global burden of cholera, and the emergence and spread of new variants that will significantly influence the clinical management of cholera and its prevention. 
Conclusion
What is known about this topic
